Research & Literature

Eczema Herpeticum: Would You Know It If You Saw It?

Blanter M, Vickers J, Russo M, Safai B

Pediatric emergency care 2015; (31(8)):586-8 doi:10.1097/PEC.0000000000000516.

Contact dermatitis in the construction industry: the role of filaggrin loss-of-function mutations.

Timmerman JG, Heederik D, Spee T, et al.

The British journal of dermatology 2016; (174(2)):348-55 doi:10.1111/bjd.14215.

Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial.

Thaçi D, Simpson EL, Beck LA, et al.

Lancet (London, England) 2016; (387(10013)):40-52.

Atopic Dermatitis: A Common Pediatric Condition and Its Evolution in Adulthood.

Gupta D

The Medical clinics of North America 2015; (99(6)):1269-85, xii.

Qualitative vs. quantitative atopic dermatitis criteria - in historical and present perspectives.

Andersen RM, Thyssen JP, Maibach HI

Journal of the European Academy of Dermatology and Venereology : JEADV 2016; (30(4)):604-18 doi:10.1111/jdv.13442.

Atopic eczema.

Brown SJ

Clinical medicine (London, England) 2016; (16(1)):66-9 doi:10.7861/clinmedicine.16-1-66.

Association between atopic dermatitis and attention deficit hyperactivity disorder in U.S. children and adults.

Strom MA, Fishbein AB, Paller AS, Silverberg JI

The British journal of dermatology 2016; (175(5)):920-929 doi:10.1111/bjd.14697.

Oral treatment with valacyclovir for HSV-2-associated eczema herpeticum in a 9-month-old infant: A case report.

Zhuang K, Wu Q, Ran X, et al.

Medicine 2016; (95(29)):e4284 doi:10.1097/MD.0000000000004284.

Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.

Simpson EL, Bieber T, Guttman-Yassky E, et al.

The New England journal of medicine 2016; (375(24)):2335-2348 doi:10.1056/NEJMoa1610020.

Increasing Comorbidities Suggest that Atopic Dermatitis Is a Systemic Disorder.

Brunner PM, Silverberg JI, Guttman-Yassky E, et al.

The Journal of investigative dermatology 2017; (137(1)):18-25 doi:10.1016/j.jid.2016.08.022.

Anxiety and Depression in Patients with Atopic Dermatitis in a Southeast Asian Tertiary Dermatological Centre.

Lim VZ, Ho RC, Tee SI, et al.

Annals of the Academy of Medicine, Singapore 2016; (45(10)):451-455.

Global Associations between UVR Exposure and Current Eczema Prevalence in Children from ISAAC Phase Three.

Fuertes E, Flohr C, Silverberg JI, et al.

The Journal of investigative dermatology 2017; (137(6)):1248-1256 doi:10.1016/j.jid.2017.02.966.

[Pathophysiology of atopic blepharokeratoconjunctivitis].

Lapp T, Maier P, Jakob T, Reinhard T

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft 2017; (114(6)):504-513 doi:10.1007/s00347-017-0483-1.

Systematic Review of Diagnostic Criteria Used in Atopic Dermatitis Randomized Controlled Trials.

Vakharia PP, Chopra R, Silverberg JI

American journal of clinical dermatology 2018; (19(1)):15-22 doi:10.1007/s40257-017-0299-4.

Classification and possible bacterial infection in outpatients with eczema and dermatitis in China: A cross-sectional and multicenter study.

Wang X, Shi XD, Li LF, et al.

Medicine 2017; (96(35)):e7955 doi:10.1097/MD.0000000000007955.

Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement.

Drucker AM, Eyerich K, de Bruin-Weller MS, et al.

The British journal of dermatology 2018; (178(3)):768-775 doi:10.1111/bjd.15928.

IgG response against Staphylococcus aureus is associated with severe atopic dermatitis in children.

Totté JEE, Pardo LM, Fieten KB, et al.

The British journal of dermatology 2018; (179(1)):118-126 doi:10.1111/bjd.16153.

The prevalence of antibody responses against Staphylococcus aureus antigens in patients with atopic dermatitis: a systematic review and meta-analysis.

de Wit J, Totté JEE, van Buchem FJM, Pasmans SGMA

The British journal of dermatology 2018; (178(6)):1263-1271 doi:10.1111/bjd.16251.

Temporal variation of Staphylococcus aureus clonal complexes in atopic dermatitis: a follow-up study.

Clausen ML, Edslev SM, Nørreslet LB, et al.

The British journal of dermatology 2019; (180(1)):181-186 doi:10.1111/bjd.17033.

Experiences with the first eczema school in the United States.

Grossman SK, Schut C, Kupfer J, et al.

Clinics in dermatology 2018; (36(5)):662-667 doi:10.1016/j.clindermatol.2018.05.006.

The role of expanded series patch testing in identifying causality of residual facial dermatitis following initiation of dupilumab therapy.

Suresh R, Murase JE

JAAD case reports 2018; (4(9)):899-904 doi:10.1016/j.jdcr.2018.08.027.

Different definitions of atopic dermatitis: impact on prevalence estimates and associated risk factors.

Nakamura T, Haider S, Colicino S, et al.

The British journal of dermatology 2019; (181(6)):1272-1279 doi:10.1111/bjd.17853.

An 8-Month-Old Girl With Vesicular Rash.

Ozcan A, Kahale K, Nguyen D

Global pediatric health 2019; (6()):2333794X19838526 doi:10.1177/2333794X19838526.

One-third of patients with therapy-resistant atopic dermatitis may benefit after patch testing.

López-Jiménez EC, Marrero-Alemán G, Borrego L

Journal of the European Academy of Dermatology and Venereology : JEADV 2019; (33(10)):e377-e378 doi:10.1111/jdv.15672.

[Atopic eczema and microbiome].

Reiger M, Schwierzeck V, Traidl-Hoffmann C

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete 2019; (70(6)):407-415 doi:10.1007/s00105-019-4424-6.

Clinical onset of atopic eczema: Results from 2 nationally representative British birth cohorts followed through midlife.

Abuabara K, Ye M, McCulloch CE, et al.

The Journal of allergy and clinical immunology 2019; (144(3)):710-719 doi:10.1016/j.jaci.2019.05.040.

Punched-out erosions with scalloped borders: Group A Streptococcal pustulosis.

Shayegan LH, Richards LE, Morel KD, Levin LE

Pediatric dermatology 2019; (36(6)):995-996 doi:10.1111/pde.13956.

Tiger-like mycosis fungoides: an unusual clinical presentation of a rare variant of mycosis fungoides.

Ahmad A, Semkova K, Stefanato CM, et al.

Dermatology online journal 2019; (25(7)).

The IL-13-OVOL1-FLG axis in atopic dermatitis.

Furue K, Ito T, Tsuji G, et al.

Immunology 2019; (158(4)):281-286 doi:10.1111/imm.13120.

Atopic Dermatitis in Adults.

Silverberg JI

The Medical clinics of North America 2020; (104(1)):157-176 doi:10.1016/j.mcna.2019.08.009.

Filaggrin loss-of-function mutations and levels of filaggrin degradation products in adult patients with atopic dermatitis in Croatia.

Jurakic Toncic R, Kezic S, Jakasa I, et al.

Journal of the European Academy of Dermatology and Venereology : JEADV 2020; (34(8)):1789-1794 doi:10.1111/jdv.16232.

Osteomyelitis complicating secondarily infected atopic eczema: two case reports and a narrative literature review.

Masuka JT, Troisi K, Mkhize Z

BMC dermatology 2020; (20(1)):2 doi:10.1186/s12895-019-0098-0.

[Late-onset atopic dermatitis with nummular pattern].

Pautt-Lara E, Cala-Castro L, Harris O, Villarinho AL

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) 2019; (66(4)):483-487 doi:10.29262/ram.v66i4.552.

Recent advances in atopic dermatitis.

Ahn K, Kim BE, Kim J, Leung DY

Current opinion in immunology 2020; (66()):14-21 doi:10.1016/j.coi.2020.02.007.

Skin pH-dependent Staphylococcus aureus abundance as predictor for increasing atopic dermatitis severity.

Hülpüsch C, Tremmel K, Hammel G, et al.

Allergy 2020; (75(11)):2888-2898 doi:10.1111/all.14461.

Associations of second-hand smoke exposure with hand eczema and atopic dermatitis among college students in China.

Jing D, Li J, Tao J, et al.

Scientific reports 2020; (10(1)):17400 doi:10.1038/s41598-020-74501-2.

Systemic treatments in the management of atopic dermatitis: A systematic review and meta-analysis.

Siegels D, Heratizadeh A, Abraham S, et al.

Allergy 2021; (76(4)):1053-1076 doi:10.1111/all.14631.

Basics and recent advances in the pathophysiology of atopic dermatitis.

Nakahara T, Kido-Nakahara M, Tsuji G, Furue M

The Journal of dermatology 2021; (48(2)):130-139 doi:10.1111/1346-8138.15664.

Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement.

Nash P, Kerschbaumer A, Dörner T, et al.

Annals of the rheumatic diseases 2021; (80(1)):71-87 doi:10.1136/annrheumdis-2020-218398.

ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children.

Wollenberg A, Christen-Zäch S, Taieb A, et al.

Journal of the European Academy of Dermatology and Venereology : JEADV 2020; (34(12)):2717-2744 doi:10.1111/jdv.16892.

Therapeutic targeting of the IL-13 pathway in skin inflammation.

Tubau C, Puig L

Expert review of clinical immunology 2021; (17(1)):15-25 doi:10.1080/1744666X.2020.1858802.

Measurement properties of patient-reported outcome measures for eczema control: a systematic review.

Stuart BL, Howells L, Pattinson RL, et al.

Journal of the European Academy of Dermatology and Venereology : JEADV 2021; (35(10)):1987-1993 doi:10.1111/jdv.17335.

The pruritogenic role of the type 2 immune response in diseases associated with chronic itch.

Ingrasci G, Lipman ZM, Hawash AA, et al.

Experimental dermatology 2021; (30(9)):1208-1217 doi:10.1111/exd.14401.

Phenotypes of atopic dermatitis and the risk for subsequent asthma: A systematic review and meta-analysis.

Li H, Dai T, Liu C, et al.

Journal of the American Academy of Dermatology 2022; (86(2)):365-372 doi:10.1016/j.jaad.2021.07.064.

Filaggrin mutations in relation to skin barrier and atopic dermatitis in early infancy.

Hoyer A, Rehbinder EM, Färdig M, et al.

The British journal of dermatology 2022; (186(3)):544-552 doi:10.1111/bjd.20831.

Microbiologic characterisation of bacterial infections in children with atopic dermatitis.

Zwane NO, Masuka JT, Chateau AV, Mosam A

Southern African journal of infectious diseases 2022; (37(1)):368 doi:10.4102/sajid.v37i1.368.

Extensive eczema herpeticum in a previously well child.

Almoalem M, AlAlhareth I, Alomer H, et al.

International journal of emergency medicine 2022; (15(1)):21 doi:10.1186/s12245-022-00425-5.

JAK in the [Black] Box: A Dermatology Perspective on Systemic JAK Inhibitor Safety.

Elmariah SB, Smith JS, Merola JF

American journal of clinical dermatology 2022; (23(4)):427-431 doi:10.1007/s40257-022-00701-3.

Pollen Food Allergy Syndrome in Allergic March.

Yasudo H, Yamamoto-Hanada K, Yang L, et al.

Nutrients 2022; (14(13)) doi:10.3390/nu14132658.

Genetic Variants in Epidermal Differentiation Complex Genes as Predictive Biomarkers for Atopic Eczema, Allergic Sensitization, and Eczema-Associated Asthma in a 6-Year Follow-Up Case-Control Study in Children.

Dębińska A, Danielewicz H, Sozańska B

Journal of clinical medicine 2022; (11(16)) doi:10.3390/jcm11164865.

Staphylococcus aureus causes aberrant epidermal lipid composition and skin barrier dysfunction.

Kim J, Kim BE, Berdyshev E, et al.

Allergy 2023; (78(5)):1292-1306 doi:10.1111/all.15640.

Guidelines of care for the management of atopic dermatitis in adults with topical therapies.

Sidbury R, Alikhan A, Bercovitch L, et al.

Journal of the American Academy of Dermatology 2023; (89(1)):e1-e20 doi:10.1016/j.jaad.2022.12.029.

Might biologics serve to interrupt the atopic march?

Spergel JM, Du Toit G, Davis CM

The Journal of allergy and clinical immunology 2023; (151(3)):590-594 doi:10.1016/j.jaci.2023.01.001.

Efficacy and Safety of JAK1 Inhibitor Abrocitinib in Atopic Dermatitis.

Iznardo H, Roé E, Serra-Baldrich E, Puig L

Pharmaceutics 2023; (15(2)) doi:10.3390/pharmaceutics15020385.

Indoor aeroallergens from American cockroaches and mites initiate atopic march via cutaneous contact in a murine model.

Lee MF, Chu YW, Wu CS, et al.

PloS one 2023; (18(7)):e0289138 doi:10.1371/journal.pone.0289138.

The immunological and structural epidermal barrier dysfunction and skin microbiome in atopic dermatitis-an update.

Çetinarslan T, Kümper L, Fölster-Holst R

Frontiers in molecular biosciences 2023; (10()):1159404 doi:10.3389/fmolb.2023.1159404.

[Eccema herpético en una paciente con dermatitis atópica].

Pavía Espinosa MR, Huchim Peña CJ, Escalante Buendía EA, et al.

Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) 2023; (70(4)):163-166 doi:10.29262/ram.v70i3.1212.

Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies.

Davis DMR, Drucker AM, Alikhan A, et al.

Journal of the American Academy of Dermatology 2024; (90(2)):e43-e56 doi:10.1016/j.jaad.2023.08.102.

Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations.

, Chu DK, Schneider L, et al.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2024; (132(3)):274-312 doi:10.1016/j.anai.2023.11.009.

Treatment of atopic dermatitis: Recently approved drugs and advanced clinical development programs.

Müller S, Maintz L, Bieber T

Allergy 2024; (79(6)):1501-1515 doi:10.1111/all.16009.

Antigen Protease Activity on Intact or Tape-Stripped Skin Induces Acute Itch and T Helper Sensitization Leading to Airway Eosinophilia in Mice.

Kimitsu T, Kamijo S, Yoshimura T, et al.

JID innovations : skin science from molecules to population health 2024; (4(1)):100239 doi:10.1016/j.xjidi.2023.100239.

Correlation Analysis of Clinician- and Patient-Reported Outcomes Among Japanese Adults with Atopic Dermatitis.

Saeki H, Kataoka Y, Etoh T, et al.

Dermatology and therapy 2024; (14(2)):533-543 doi:10.1007/s13555-023-01094-9.

Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Clinical Trials (Measure Up 1 and Measure Up 2).

Silverberg JI, Gooderham MJ, Paller AS, et al.

American journal of clinical dermatology 2024; (25(3)):485-496 doi:10.1007/s40257-024-00853-4.

Treatment of atopic dermatitis with upadacitinib: adcare single center experience.

Fomina DS, Mukhina OA, Mikhailova VI, et al.

Frontiers in medicine 2024; (11()):1385720 doi:10.3389/fmed.2024.1385720.

Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2).

Simpson EL, Prajapati VH, Leshem YA, et al.

Dermatology and therapy 2024; (14(5)):1127-1144 doi:10.1007/s13555-024-01157-5.

Kaposi's Varicelliform Eruption: A Potentially Life-Threatening Complication of Atopic Dermatitis.

Martín-Galache M, Escalona-Gil AM, Posado-Domínguez L, et al.

European journal of case reports in internal medicine 2024; (11(5)):004392 doi:10.12890/2024_004392.

Patch test in Brazilian children with a clinical diagnosis of atopic dermatitis: a cross-sectional study using an extended patch test battery.

Rigolon JR, Barbosa SS, Goudouris ES

Allergologia et immunopathologia 2024; (52(3)):78-86 doi:10.15586/aei.v52i3.1024.

Systemic Biologic Management of Atopic Dermatitis.

Dao DD, Flowers RH

Advances in experimental medicine and biology 2024; (1447()):139-149 doi:10.1007/978-3-031-54513-9_13.

Sezary Syndrome: A Case Report and Review of Current Therapeutics.

Krishnan J, Thanikachalam K

Cureus 2024; (16(4)):e58570 doi:10.7759/cureus.58570.

Reduced atopic march risk in pediatric atopic dermatitis patients prescribed dupilumab versus conventional immunomodulatory therapy: A population-based cohort study.

Lin TL, Fan YH, Fan KS, et al.

Journal of the American Academy of Dermatology 2024; (91(3)):466-473 doi:10.1016/j.jaad.2024.05.029.

Cross-Cultural Validation of the RECAP of Atopic Eczema Question-naire in a Swedish Population.

Sigurdardottir G, Alsterholm M, Andersson CD, et al.

Acta dermato-venereologica 2024; (104()):adv38889 doi:10.2340/actadv.v104.38889.

Practical Recommendations on Laboratory Monitoring in Patients with Atopic Dermatitis on Oral JAK Inhibitors.

Kirchhof MG, Prajapati VH, Gooderham M, et al.

Dermatology and therapy 2024; (14(9)):2653-2668 doi:10.1007/s13555-024-01243-8.

Risk factors and temporal associations of progression of the atopic march in children with early-onset atopic dermatitis.

Choi UE, Deng J, Parthasarathy V, et al.

Journal of the American Academy of Dermatology 2025; (92(4)):732-740 doi:10.1016/j.jaad.2024.10.107.

The management of severe eczema in pregnancy.

Keeling E, Smith CH, Woolf RT

Clinical medicine (London, England) 2025; (25(1)):100282 doi:10.1016/j.clinme.2024.100282.

Woman with a Painful Rash.

Shalabi L, Eilbert W

Clinical practice and cases in emergency medicine 2025; (9(1)):107-108 doi:10.5811/cpcem.20735.

Infections in Patients with Atopic Dermatitis and the Influence of Treatment.

Napolitano M, Esposito M, Fargnoli MC, et al.

American journal of clinical dermatology 2025; (26(2)):183-197 doi:10.1007/s40257-025-00917-z.

Describing atopic dermatitis in real-world clinical practice: a retrospective health system analysis.

Polaskey MT, Chovatiya R

Archives of dermatological research 2025; (317(1)):365 doi:10.1007/s00403-025-03892-x.

Interleukin-4 and Atopic Dermatitis: Why Does it Matter? A Narrative Review.

Torres T, Mendes-Bastos P, Cruz MJ, et al.

Dermatology and therapy 2025; (15(3)):579-597 doi:10.1007/s13555-025-01352-y.

Evaluating the Real-World Effectiveness of Systemic Treatments in Atopic Dermatitis Using the Atopic Dermatitis Control Tool (ADCT): A Multi-Centre, Prospective Study.

Lee HJ, Woo Y, Lee YB, et al.

Acta dermato-venereologica 2025; (105()):adv40704 doi:10.2340/actadv.v105.40704.

Atopic Dermatitis in Adults: Focus on Topical Therapy.

Marshall LL

The Senior care pharmacist 2025; (40(3)):123-134 doi:10.4140/TCP.n.2025.123.

Melano-erythrodermic folliculotropic mycosis fungoides misdiagnosed as a case of recalcitrant atopic dermatitis: A case report.

Alghamdi N, Alzammami H, Alfaraj MM

SAGE open medical case reports 2025; (13()):2050313X251320468 doi:10.1177/2050313X251320468.

Type 2 Inflammation and Its Role in Dermatologic Diseases.

Chovatiya R, Hawkes JE, DiRuggiero D, et al.

International journal of dermatology 2025; (64(6)):978-991 doi:10.1111/ijd.17707.

Exposure to per-and poly-fluoroalkyl substances and respiratory and skin effects in children and adolescents: A systematic review and meta-analysis.

Hatem G, Faria AM, Pinto MB, et al.

Journal of hazardous materials 2025; (491()):137978 doi:10.1016/j.jhazmat.2025.137978.

Assessing the Clinical Efficacy of Dupilumab and Its Impact on the Quality of Life of Adult Atopic Dermatitis Patients: A Systematic Review.

Krissheeven M, Nunkoo S, Ramanah M, et al.

Cureus 2025; (17(2)):e79762 doi:10.7759/cureus.79762.

Consensus on the Use of JAKinibs for Atopic Dermatitis in Australia and New Zealand. An eDelphi by the Australasian Medical Dermatology Group.

Rademaker M, Foley P, Armour K, et al.

The Australasian journal of dermatology 2025; (66(5)):e287-e296 doi:10.1111/ajd.14525.

A practical algorithm for the treatment of mild-to-moderate atopic dermatitis (AD) in pediatric patients in Europe: expert recommendations.

Augustin M, Luger T, Pincelli C, et al.

The Journal of dermatological treatment 2025; (36(1)):2503281 doi:10.1080/09546634.2025.2503281.

Understanding Atopic Dermatitis: Pathophysiology and Management Strategies.

Chai H, Siu WS, Ma H, Li Y

Biomolecules 2025; (15(11)) doi:10.3390/biom15111500.

Efficacy and Safety of Abrocitinib in an Elderly Chinese Population with Moderate-to-Severe Atopic Dermatitis: A Non-randomized Controlled Trial.

Zhang Q, Zhu Y, Yang L, et al.

Acta dermato-venereologica 2025; (105()):adv44200 doi:10.2340/actadv.v105.44200.

Sensitive skin in patients with inflammatory chronic cutaneous disorders: results from an observational study on psoriasis, atopic dermatitis and hand eczema.

Borghi A, Guarneri F, Pacetti L, et al.

Italian journal of dermatology and venereology 2026; (161(2)):97-103 doi:10.23736/S2784-8671.25.08299-4.

Dupilumab therapy in atopic dermatitis when cutaneous lymphoma is suspected: Consensus recommendations from the EORTC Cutaneous Lymphoma Tumour Group.

Calvão J, de Masson A, Cozzio A, et al.

The Journal of allergy and clinical immunology 2026; (157(6)):1237-1245 doi:10.1016/j.jaci.2026.04.002.

The Impact of Dupilumab on Psychological Wellbeing in Moderate-to-Severe Atopic Dermatitis Patients: A Phase IV Clinical Trial.

Johnson CE, Elhage KG, Spencer RK, et al.

The Journal of clinical and aesthetic dermatology 2026; (19(3)):15-19.

Evaluation and work-up of atopic dermatitis.

Zhu J, Abuabara K

Journal of the American Academy of Dermatology 2026; (94(5S)):S24-S27 doi:10.1016/j.jaad.2026.02.094.

IL-4/IL-13-Driven Dysregulation of Epidermal Lipid Metabolism in Atopic Dermatitis: An Immunometabolic Link Between Type 2 Inflammation and Barrier Dysfunction.

Andrzejczak K, Sternak A, Witkowski W, et al.

Cells 2026; (15(12)) doi:10.3390/cells15121130.

Optimizing Abrocitinib Use for Atopic Dermatitis in India: Expert Recommendations for Patient Selection, Dosing, and Long‑Term Remission.

Kandhari S, De A, Shankar K, et al.

Clinical, cosmetic and investigational dermatology 2026; (19()):611587 doi:10.2147/CCID.S611587.